---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-169285"
form_type: "8-K"
ticker: "HOWL"
cik: "0001785530"
company_name: "Werewolf Therapeutics, Inc."
filed_at: "2022-06-07T23:59:59+00:00"
generated_at: "2026-06-25T04:01:32.614271+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "high"
source: SEC EDGAR
---

# Werewolf Therapeutics announces annual meeting voting results; directors elected and auditor ratified

## Summary
- Stockholders elected Briggs Morrison and Michael Sherman as Class I directors for three-year terms ending in 2025.
- Ratification of Deloitte & Touche as auditor for FY2022 passed with 23,945,185 votes for, 1,694 against, 12 abstain.
- Broker non-votes on director elections totaled 3,626,970.
- No other material proposals were presented at the meeting.

## SEC filing metadata
- accession: 0001193125-22-169285
- form_type: 8-K
- ticker: HOWL
- cik: 0001785530
- company_name: Werewolf Therapeutics, Inc.
- filed_at: 2022-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1785530/000119312522169285/0001193125-22-169285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1785530/000119312522169285/d286266d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-169285
- JSON: https://secwatch.observer/filing/0001193125-22-169285.json
- Plain text: https://secwatch.observer/filing/0001193125-22-169285.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.